Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemical Recurrence of Malignant Neoplasm of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04978675
What this trial is testing

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaProstate Adenocarcinoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT03810105
What this trial is testing

Olaparib and Durvalumab in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT03513211
What this trial is testing

Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
St Vincent's Hospital, Sydney 12
Testing effectiveness (Phase 2)Ended earlyNCT04336943
What this trial is testing

Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
University of Washington 6
Large-scale testing (Phase 3)UnknownNCT05847348
What this trial is testing

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of ProstateProstate CancerBCR Prostate Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 110
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009967
What this trial is testing

Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Large-scale testing (Phase 3)Study completedNCT00672282
What this trial is testing

Casodex vs Placebo in Non-Metastatic Early Prostate Cancer

Who this might be right for
Non-Metastatic Prostate Cancer
AstraZeneca 1,218
Early research (Phase 1)Study completedNCT04216134
What this trial is testing

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate Carcinoma
City of Hope Medical Center 19
Not applicableUnknownNCT03212456
What this trial is testing

Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia

Who this might be right for
Prostate Cancer
Instituto do Cancer do Estado de São Paulo 146
Testing effectiveness (Phase 2)Study completedNCT05249127
What this trial is testing

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 52
Testing effectiveness (Phase 2)Study completedNCT00499408
What this trial is testing

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 26
Early research (Phase 1)Active Not RecruitingNCT05077098
What this trial is testing

Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
Mark Stein 8
Large-scale testing (Phase 3)Looking for participantsNCT07831824
What this trial is testing

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

Who this might be right for
Prostate Cancer
Lantheus Medical Imaging 408
Large-scale testing (Phase 3)Study completedNCT00673205
What this trial is testing

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

Who this might be right for
Non-Metastatic Prostate Cancer
AstraZeneca 3,588
Large-scale testing (Phase 3)Study completedNCT03389451
What this trial is testing

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmProstatic Neoplasms, Castration-Resistant+2 more
Michael Graham PhD, MD 30
Large-scale testing (Phase 3)Ended earlyNCT05744115
What this trial is testing

Ga-68-PSMA-11 in Men With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Timothy Hoffman 38
Large-scale testing (Phase 3)Study completedNCT00925600
What this trial is testing

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Who this might be right for
CancerCataractLow Bone Mineral Density+3 more
Amgen 769
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Next Page